Drugs / peptides derived from antiapoptotic proteins
peptides derived from antiapoptotic proteins
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01272466 | Feb 2010 → Feb 2012 | plasma cell myeloma | Herlev Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | peptides derived from antiapoptotic proteins | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01272466 ↗ |
| Modality | Vaccine | “vaccination with peptides derived from antiapoptotic proteins” NCT01272466 ↗ |